Bayer Aktiengesellschaft against Sanofi — live side-by-side technical comparison.
Prices as of 2026-09-23T15:37:33+00:00 UTC · updates daily
BAYN.DE leads 5 of the 5 windows we measure — over 1 month BAYN.DE is +1.7% and SNY -8.8%; over year to date BAYN.DE is +33.2% and SNY -14.0%.
| BAYN.DE | SNY | |
|---|---|---|
| Price | $49.31 | $41.66 |
| 1 day | -0.5%lead | -2.0% |
| 5 days | +0.7%lead | -2.2% |
| 1 month | +1.7%lead | -8.8% |
| 6 months | +28.2%lead | -7.0% |
| Year to date | +33.2%lead | -14.0% |
| 52-week position | 84% of range | 7% of range |
| 52-week range | $25.78–$53.92 | $40.89–$52.68 |
| vs 50-day average | above $48.45 | below $43.82 |
| vs 200-day average | above $42.54 | below $45.32 |
| RSI (14) | 50 | 25 |
| Next earnings | 2026-11-03 | 2026-10-30 |
BAYN.DE trades at $49.31, above its 50-day average of $48.45, and above the 200-day at $42.54. It sits at 84% of its 52-week range ($25.78–$53.92); 14-day RSI is 50, in neutral territory; an average session moves it about 2.5%. For levels, the first level overhead is $50.00 (1.4% away) and the first support below is $48.45 (1.7% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
SNY trades at $41.66, below its 50-day average of $43.82, and below the 200-day at $45.32. It sits at 7% of its 52-week range ($40.89–$52.68); 14-day RSI is 25, in oversold territory; an average session moves it about 1.7%. For levels, the first level overhead is $42.31 (1.6% away) and the first support below is $41.33 (0.8% down). On the checklist the page runs for every asset, 0 of 6 checks read bullish — the lean is bearish.
BAYN.DE is the more volatile of the two — an average session moves it 2.5% against 1.7% for SNY, so an identical position size carries roughly 1.5× the daily risk.
The comparison turns on those levels: BAYN.DE clearing $50.00 or losing $48.45; SNY clearing $42.31 or losing $41.33. Until one of them gives way, the relative reading above stands.